UPDATE: Morgan Keegan Lowers PT on Skilled Healthcare Group to $14

Morgan Keegan is out with its report today on Skilled Healthcare Group SKH, lowering its PT from $18 to $14. In a note to clients, Morgan Keegan writes, "We believe that SKH can grow earnings by providing high-acuity medically complex services to short-stay patients at its owned and leased nursing homes. We expect the company to augment this internal growth through accretive acquisitions. While we have not changed our 2012 estimates, our price target has been lowered from $18 to $14, but we maintain our Outperform rating." Shares of SKH closed Friday at $10.95, up 4.39% from Thursday's close.